300 related articles for article (PubMed ID: 32063481)
1. Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review.
Fortunato L; Bennardo F; Buffone C; Giudice A
J Craniomaxillofac Surg; 2020 Mar; 48(3):268-285. PubMed ID: 32063481
[TBL] [Abstract][Full Text] [Related]
2. Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review.
Lopez-Jornet P; Sanchez Perez A; Amaral Mendes R; Tobias A
J Craniomaxillofac Surg; 2016 Aug; 44(8):1067-72. PubMed ID: 27318752
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of complementary treatment with autologous platelet concentrates and/or mesenchymal stem cells in chemical osteonecrosis of the jaw. Systematic review of the literature.
Escobedo MF; Junquera S; Gonzalez C; Vasatyuk S; Gallego L; Barbeito E; Junquera LM
J Stomatol Oral Maxillofac Surg; 2022 Feb; 123(1):51-58. PubMed ID: 33609789
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of autologous platelet concentrates in prevention and treatment of medication-related osteonecrosis of the jaws: A systematic review.
Nowak SM; Sacco R; Mitchell FL; Patel V; Gurzawska-Comis K
J Craniomaxillofac Surg; 2024 Jun; 52(6):671-691. PubMed ID: 38644092
[TBL] [Abstract][Full Text] [Related]
5. Autologous platelet concentrates in treatment of medication related osteonecrosis of the jaw.
Rusilas H; Balčiūnaitė A; Žilinskas J
Stomatologija; 2020; 22(1):23-27. PubMed ID: 32706343
[TBL] [Abstract][Full Text] [Related]
6. Laser Devices and Autologous Platelet Concentrates in Prevention and Treatment of Medication-Related Osteonecrosis of the Jaws: A Systematic Review.
Scribante A; Ghizzoni M; Pellegrini M; Pulicari F; Spadari F
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241204
[No Abstract] [Full Text] [Related]
7. Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: A systematic review with meta-analyses.
Karna H; Gonzalez J; Radia HS; Sedghizadeh PP; Enciso R
Oral Oncol; 2018 Oct; 85():15-23. PubMed ID: 30220314
[TBL] [Abstract][Full Text] [Related]
8. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.
Del Fabbro M; Gallesio G; Mozzati M
Eur J Cancer; 2015 Jan; 51(1):62-74. PubMed ID: 25466505
[TBL] [Abstract][Full Text] [Related]
9. The Role of Autologous Platelet Concentrates in the Treatment of Medication-Related Osteonecrosis of the Jaw.
Ye P; Wei T; Lu ZY; Cai YJ
J Craniofac Surg; 2021 Mar-Apr 01; 32(2):621-625. PubMed ID: 33704995
[TBL] [Abstract][Full Text] [Related]
10. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
[TBL] [Abstract][Full Text] [Related]
11. Autologous Platelet Concentrates (APCs) for Hard Tissue Regeneration in Oral Implantology, Sinus Floor Elevation, Peri-Implantitis, Socket Preservation, and Medication-Related Osteonecrosis of the Jaw (MRONJ): A Literature Review.
Mijiritsky E; Assaf HD; Kolerman R; Mangani L; Ivanova V; Zlatev S
Biology (Basel); 2022 Aug; 11(9):. PubMed ID: 36138733
[TBL] [Abstract][Full Text] [Related]
12. The Prevention of Medication-related Osteonecrosis of the Jaw.
Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
[TBL] [Abstract][Full Text] [Related]
13. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
Kawahara M; Kuroshima S; Sawase T
Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
[TBL] [Abstract][Full Text] [Related]
14. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
15. Medication-related Osteonecrosis of the Jaw Induced by Regenerative Therapy in Implant Dentistry: A Scoping Review.
Al-Omari FA; Kuroshima S; Sawase T
J Dent; 2023 Nov; 138():104682. PubMed ID: 37708930
[TBL] [Abstract][Full Text] [Related]
16. The role of leukocyte and platelet-rich fibrin in the prevention of medication-related osteonecrosis of the jaw, in patients requiring dental extractions: an observational study.
Besi E; Pitros P
Oral Maxillofac Surg; 2024 Jun; 28(2):785-793. PubMed ID: 38182917
[TBL] [Abstract][Full Text] [Related]
17. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review.
Sher J; Kirkham-Ali K; Luo JD; Miller C; Sharma D
J Oral Implantol; 2021 Jun; 47(3):249-268. PubMed ID: 32699903
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapies for MRONJ: A systematic review.
Govaerts D; Piccart F; Ockerman A; Coropciuc R; Politis C; Jacobs R
Bone; 2020 Dec; 141():115676. PubMed ID: 33022455
[TBL] [Abstract][Full Text] [Related]
19. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
[TBL] [Abstract][Full Text] [Related]
20. Treatment of medication-related osteonecrosis of the jaw (MRONJ). A systematic review.
Goker F; Grecchi E; Grecchi F; Francetti L; Del Fabbro M
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2662-2673. PubMed ID: 33829453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
